The development of vaccines has been one of the greatest advances in the history of medicine, transforming the prevention of infectious diseases over the past two centuries. Vaccines stimulate the immune system to provide protection in the absence of disease, which has reduced morbidity and mortality from diseases caused by microbial pathogens.

With the aim of introducing the different chemical technologies that have been used in the development of preventive antiviral and antibacterial vaccines, Dr. Daniel García Rivera (University of Havana-GLACIER) will present the course “Chemical Technologies for Vaccine Development” at the Institute of Chemistry, UNAM (Mexico City, Mexico) on 28 May 2025.

The course will be divided into three sections:

1. Introduction to vaccine development and the different vaccine platforms.
2. Recombinant and glycoconjugated protein vaccine technology.
3. Messenger RNA vaccine technology and non-viral gene delivery systems.

The course will address issues related to the development of site-selective protein modification methods and the conjugation of carrier proteins to antigenic peptides, proteins and oligosaccharides of viral or bacterial origin. Progress in lipid nanoparticle technology for the delivery of nucleic acids, essential for the development of messenger RNA vaccines, will also be described.